PJT Partners Inc is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock has positive analyst sentiment and exposure to large-cap M&A activity, the technical indicators suggest the stock is currently overbought, and there are no strong trading signals or recent news catalysts to justify immediate action. Additionally, the financial performance shows mixed results, with a significant drop in EPS despite revenue and net income growth.
The MACD is positive at 3.346, indicating bullish momentum, but it is contracting. RSI is at 91.438, signaling an overbought condition. Moving averages are converging, which suggests indecision in the market. The stock is trading near its R1 resistance level of 162.043, with further resistance at 168.894.

Positive analyst upgrades from Keefe Bruyette and Goldman Sachs, highlighting PJT's exposure to large-cap M&A and attractive valuation. Revenue and net income growth in Q4 2025.
RSI indicates overbought conditions, and there is no recent news to act as a catalyst. EPS has dropped significantly YoY, and gross margin remains at 0%. No significant insider or hedge fund trading trends.
In Q4 2025, revenue increased by 12.13% YoY to $535.16M, and net income grew by 4.01% YoY to $53.36M. However, EPS dropped by -132.24% YoY to -0.59, indicating profitability challenges.
Recent analyst ratings are mixed but lean positive. UBS maintains a Neutral rating with a $152 price target. Keefe Bruyette upgraded the stock to Outperform with a $166 target, and Goldman Sachs upgraded it to Buy with a $170 target, citing attractive valuation and exposure to strategic M&A.